LabConnect, a United States company that offers central laboratory and support services for biopharmaceutical, medical device and contract research organisations, has named Sam Osman as its new director, it was reported on Tuesday.

Osman has 20 years of experience as a life science leader. He has held the position of CEO of Cenduit and roles of increasing responsibility at Quintiles, now IQVIA. He has also worked in investment banking.

Eric Richman, chairman of the LabConnect board of directors, said, 'Sam is an important addition to our Board of Directors. His deep experience in pharma services operations and M&A will support LabConnect exceptional domestic and international growth. We are delighted to welcome him to LabConnect and look forward to benefiting from his insights, which we believe will help us advance our goal of supporting complex clinical studies in biopharma to bring important new drugs to patients in need.'